Indication

Non-erosive Gastroesophageal Reflux Disease

1 clinical trial

2 products

Clinical trial

A Multicenter, Randomized, Parallel, Double-Blinded, Placebo-controlled Phase 3 Study to Compare Efficacy and Safety of HIP1601 in Patients With Non-Erosive Gastroesophageal Reflux Disease(NERD)

Status: Completed, Estimated PCD: 2020-08-03

Product

Product